These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23888304)

  • 1. Predictive factors for agitation severity of hyperactive delirium in terminally ill cancer patients in a general hospital using ordered logistic regression analysis.
    Kanbayashi Y; Hatano Y; Hata Y; Morita T; Fukui K; Hosokawa T
    J Palliat Med; 2013 Sep; 16(9):1020-5. PubMed ID: 23888304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of pneumonia on hyperactive delirium in end-stage lung cancer patients.
    Suzuki H; Hirashima T; Kobayashi M; Okamoto N; Matsuura Y; Tamiya M; Morishita N; Okafuji K; Shiroyama T; Morimura O; Morita S; Kawase I
    Support Care Cancer; 2013 Jan; 21(1):281-5. PubMed ID: 22710844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinical study on the influence of hydration volume on the signs of terminally ill cancer patients with abdominal malignancies.
    Nakajima N; Hata Y; Kusumuto K
    J Palliat Med; 2013 Feb; 16(2):185-9. PubMed ID: 23327196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for agitation and hyperactive delirium in adult postcardiotomy patients with extracorporeal membrane oxygenation support: an observational study.
    Wang H; Hou D; Tian X; Wang L; Li C; Jia M; Hou X
    Perfusion; 2020 Sep; 35(6):534-542. PubMed ID: 32627668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective chart review of terminal patients with cancer with agitation and their risk factors.
    Nagase M; Okamoto Y; Tsuneto S; Tanimukai H; Matsuda Y; Okishiro N; Oono Y; Tsugane M; Takagi T; Uejima E
    J Palliat Med; 2012 Nov; 15(11):1185-90. PubMed ID: 22917275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smoking Cessation and the Risk of Hyperactive Delirium in Hospitalized Patients: A Retrospective Study.
    Park H; Kim KW; Yoon IY
    Can J Psychiatry; 2016 Oct; 61(10):643-51. PubMed ID: 27310248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Communication Capacity Scale and Agitation Distress Scale to measure the severity of delirium in terminally ill cancer patients: a validation study.
    Morita T; Tsunoda J; Inoue S; Chihara S; Oka K
    Palliat Med; 2001 May; 15(3):197-206. PubMed ID: 11407191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delirium, agitation, and symptom distress within the final seven days of life among cancer patients receiving hospice care.
    de la Cruz M; Noguera A; San Miguel-Arregui MT; Williams J; Chisholm G; Bruera E
    Palliat Support Care; 2015 Apr; 13(2):211-6. PubMed ID: 24556057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Episodes of psychomotor agitation among medical patients: findings from a longitudinal multicentre study.
    Mansutti I; Venturini M; Palese A;
    Aging Clin Exp Res; 2020 Jun; 32(6):1101-1110. PubMed ID: 31378845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agitation and delirium at the end of life: "We couldn't manage him".
    Breitbart W; Alici Y
    JAMA; 2008 Dec; 300(24):2898-910, E1. PubMed ID: 19109118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delirium prevention in terminal cancer: assessment of a multicomponent intervention.
    Gagnon P; Allard P; Gagnon B; Mérette C; Tardif F
    Psychooncology; 2012 Feb; 21(2):187-94. PubMed ID: 22271539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Environmental factors and risk of delirium in geriatric patients: an observational study.
    Evensen S; Saltvedt I; Lydersen S; Wyller TB; Taraldsen K; Sletvold O
    BMC Geriatr; 2018 Nov; 18(1):282. PubMed ID: 30442109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Statistical identification of predictors for peripheral neuropathy associated with administration of bortezomib, taxanes, oxaliplatin or vincristine using ordered logistic regression analysis.
    Kanbayashi Y; Hosokawa T; Okamoto K; Konishi H; Otsuji E; Yoshikawa T; Takagi T; Taniwaki M
    Anticancer Drugs; 2010 Oct; 21(9):877-81. PubMed ID: 20679888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphine is a reasonable alternative to haloperidol in the treatment of postoperative hyperactive-type delirium after cardiac surgery.
    Atalan N; Efe Sevim M; Akgün S; Fazlıoğulları O; Başaran C
    J Cardiothorac Vasc Anesth; 2013 Oct; 27(5):933-8. PubMed ID: 23791495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for delirium in older trauma patients admitted to the surgical intensive care unit.
    Bryczkowski SB; Lopreiato MC; Yonclas PP; Sacca JJ; Mosenthal AC
    J Trauma Acute Care Surg; 2014 Dec; 77(6):944-51. PubMed ID: 25248058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for developing delirium in older patients admitted to general medical wards.
    Srinonprasert V; Pakdeewongse S; Assanasen J; Eiamjinnasuwat W; Sirisuwat A; Limmathuroskul D; Praditsuwan R
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S99-104. PubMed ID: 21721434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agitated terminal delirium and association with partial opioid substitution and hydration.
    Morita T; Tei Y; Inoue S
    J Palliat Med; 2003 Aug; 6(4):557-63. PubMed ID: 14516497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nutritional predictors of survival in terminally ill cancer patients.
    Ho SY; Guo HR; Chen HH; Peng CJ
    J Formos Med Assoc; 2003 Aug; 102(8):544-50. PubMed ID: 14569319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delirium and its motoric subtypes: a study of 614 critically ill patients.
    Peterson JF; Pun BT; Dittus RS; Thomason JW; Jackson JC; Shintani AK; Ely EW
    J Am Geriatr Soc; 2006 Mar; 54(3):479-84. PubMed ID: 16551316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gabapentinoid Use Is Associated With Reduced Occurrence of Hyperactive Delirium in Older Cancer Patients Undergoing Chemotherapy: A Nationwide Retrospective Cohort Study in Japan.
    Abe H; Sumitani M; Matsui H; Inoue R; Konishi M; Fushimi K; Uchida K; Yasunaga H
    Anesth Analg; 2022 Aug; 135(2):362-369. PubMed ID: 35560025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.